Diaphragm pacing system receives FDA approval for use with ALS patients
Links shared publicly online about this topic.
- 0total visits
Diaphragm pacing system receives FDA approval for use with ALS patients
View full resource at medicalxpress.com
Tags: ALS, Lung, Muscle, Diet and Nutrition, Drug, FDA, disease
Most Recently Shared on September 29, 2011 at 8:45 pm By:
Diaphragm pacing system receives FDA approval for use with ALS patients http://t.co/uLfR6h75
Symposier - Diaphragm Pacing System for ALS Patients
symposier.com — “Uploaded and shared in Youtube by: UniversityHospitals — Recently approved by the FDA for use in ALS patients, diaphragm pacing significantly improves a patient's quality of life, allowing them to breathe longer without the use of a ventilator. Learn more, http://ow.ly/7yf5X.” View full resource at symposier.com
Most Recently Shared on December 22, 2011 at 5:34 pm By:
Recently approved by the FDA for use in ALS patients, diaphragm pacing significantly improves a PTs QoL http://t.co/bRmuTN4k
FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients
news-medical.net — “Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.” View full resource at news-medical.net
Most Recently Shared on October 11, 2010 at 5:50 am By:
FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients: Synapse Biomedical Inc. announces tod... http://bit.ly/dfOHGG
Synapse Biomedical Receives FDA Humanitarian Use Device Designation For Amyotrophic Lateral Sclerosis (ALS) - QualityPoint Technologies
qualitypointtech.net — “Synapse Biomedical Inc. announces that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS)" as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval...” View full resource at qualitypointtech.net
Most Recently Shared on October 9, 2010 at 4:12 pm By:
Synapse Biomedical Receives FDA Humanitarian Use Device Designation For Amyotrophic Lateral Sclerosis (ALS): Synap... http://bit.ly/9q796K
Advertisement
